Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryotherapy and Compression for Albumin-paclitaxel Induced Neuropathy
NCT05341141Recruiting
- Sponsor
- Peking University
- Start
- Jun 2022
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Peking University. Primary endpoint: Incidence of grade 3 and higher peripheral neuropathy at 4 years. Started Jun 2022; status: recruiting.
Beyond the preview
Go deeper on NCT05341141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05341141.